Soligenix Inc (NASDAQ: SNGX)’s stock price has gone decline by -6.48 in comparison to its previous close of 0.46, however, the company has experienced a -7.89% decrease in its stock price over the last five trading days. PRNewsWire reported 2024-01-25 that PRINCETON, N.J., Jan. 25, 2024 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the Company will deliver a corporate presentation at The Microcap Conference.
Is It Worth Investing in Soligenix Inc (NASDAQ: SNGX) Right Now?
Moreover, the 36-month beta value for SNGX is 1.88. Analysts have varying opinions on the stock, with 3 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for SNGX is 10.49M and currently, short sellers hold a 1.10% of that float. On April 11, 2024, SNGX’s average trading volume was 148.67K shares.
SNGX’s Market Performance
SNGX stock saw a decrease of -7.89% in the past week, with a monthly decline of -39.01% and a quarterly a decrease of -49.18%. The volatility ratio for the week is 7.82%, and the volatility levels for the last 30 days are 8.13% for Soligenix Inc (SNGX). The simple moving average for the last 20 days is -24.37% for SNGX’s stock, with a simple moving average of -27.76% for the last 200 days.
Analysts’ Opinion of SNGX
H.C. Wainwright, on the other hand, stated in their research note that they expect to see SNGX reach a price target of $2.70, previously predicting the price at $5.50. The rating they have provided for SNGX stocks is “Neutral” according to the report published on January 31st, 2018.
Maxim Group gave a rating of “Buy” to SNGX, setting the target price at $5 in the report published on August 14th of the previous year.
SNGX Trading at -33.95% from the 50-Day Moving Average
After a stumble in the market that brought SNGX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -89.69% of loss for the given period.
Volatility was left at 8.13%, however, over the last 30 days, the volatility rate increased by 7.82%, as shares sank -37.90% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -31.41% lower at present.
During the last 5 trading sessions, SNGX fell by -6.76%, which changed the moving average for the period of 200-days by -39.13% in comparison to the 20-day moving average, which settled at $0.5591. In addition, Soligenix Inc saw -42.82% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for SNGX
Current profitability levels for the company are sitting at:
- -9.46 for the present operating margin
- 0.11 for the gross margin
The net margin for Soligenix Inc stands at -7.32. The total capital return value is set at -2.18. Equity return is now at value -23783.30, with -51.01 for asset returns.
Based on Soligenix Inc (SNGX), the company’s capital structure generated 0.57 points at debt to capital in total, while cash flow to debt ratio is standing at -2.54. The debt to equity ratio resting at 1.34. The interest coverage ratio of the stock is -345.22.
Currently, EBITDA for the company is -8.42 million with net debt to EBITDA at 0.62. When we switch over and look at the enterprise to sales, we see a ratio of -0.47. The receivables turnover for the company is 4.3for trailing twelve months and the total asset turnover is 0.09. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.55.
Conclusion
To wrap up, the performance of Soligenix Inc (SNGX) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
